Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Atibuclimab by Implicit Bioscience for Cardiomyopathy: Likelihood of Approval
Atibuclimab is under clinical development by Implicit Bioscience and currently in Phase II for Cardiomyopathy. According to GlobalData, Phase II...
Data Insights
Atibuclimab by Implicit Bioscience for Parkinson's Disease: Likelihood of Approval
Atibuclimab is under clinical development by Implicit Bioscience and currently in Phase I for Parkinson's Disease. According to GlobalData, Phase...